Acurx Pharmaceuticals, Inc.ACXPNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank27
Year-over-Year Change
Year-over-year operating cash flow growth rate
Latest
-12.59%
↑ 57% vs avg
Percentile
P27
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-29.11%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | -12.59% |
| Q2 2025 | 18.57% |
| Q1 2025 | 8.84% |
| Q4 2024 | -2.77% |
| Q3 2024 | 23.97% |
| Q2 2024 | 5.96% |
| Q1 2024 | 27.03% |
| Q4 2023 | -100.51% |
| Q3 2023 | -32.78% |
| Q2 2023 | 18.43% |
| Q1 2023 | -29.24% |
| Q4 2022 | 31.40% |
| Q3 2022 | -9.51% |
| Q2 2022 | -6.11% |
| Q1 2022 | -25.05% |
| Q4 2021 | 43.10% |
| Q3 2021 | -699.42% |
| Q2 2021 | 39.72% |
| Q1 2021 | 42.99% |
| Q4 2020 | -26.49% |
| Q3 2020 | -3.41% |
| Q2 2020 | 18.41% |
| Q1 2020 | 0.00% |